Evaluation of the Effects of Genistein In Vitro as a Chemopreventive Agent for Colorectal Cancer-Strategy to Improve Its Efficiency When Administered Orally

ABSTRACT: Colorectal Cancer (CRC) ranks third in terms of incidence and second in terms of mortality and prevalence worldwide. In relation to chemotherapy treatment, the most used drug is 5-fluorouracil (5-FU); however, the use of this drug generates various toxic effects at the systemic level. For...

Full description

Autores:
Rendón Marín, Juan Pablo
Correa Gómez, Elizabeth
Bedoya Betancur, Vanesa
Cañas Gutiérrez, Ana Isabel
Osorio Orozco, Marlon
Castro Herazo, Cristina Isabel
Naranjo Preciado, Tonny Williams
Tipo de recurso:
Article of investigation
Fecha de publicación:
2022
Institución:
Universidad de Antioquia
Repositorio:
Repositorio UdeA
Idioma:
eng
OAI Identifier:
oai:bibliotecadigital.udea.edu.co:10495/41661
Acceso en línea:
https://hdl.handle.net/10495/41661
Palabra clave:
Apoptosis
Línea Celular Tumoral
Cell Line, Tumor
Neoplasias Colorrectales
Colorectal Neoplasms
Fluorouracilo
Fluorouracil
Genisteína
Genistein
Especies Reactivas de Oxígeno
Reactive Oxygen Species
Quimioprevención
Chemoprevention
https://id.nlm.nih.gov/mesh/D017209
https://id.nlm.nih.gov/mesh/D045744
https://id.nlm.nih.gov/mesh/D015179
https://id.nlm.nih.gov/mesh/D005472
https://id.nlm.nih.gov/mesh/D019833
https://id.nlm.nih.gov/mesh/D017382
https://id.nlm.nih.gov/mesh/D018890
Rights
openAccess
License
http://creativecommons.org/licenses/by/2.5/co/
Description
Summary:ABSTRACT: Colorectal Cancer (CRC) ranks third in terms of incidence and second in terms of mortality and prevalence worldwide. In relation to chemotherapy treatment, the most used drug is 5-fluorouracil (5-FU); however, the use of this drug generates various toxic effects at the systemic level. For this reason, new therapeutic strategies are currently being sought that can be used as neoadjuvant or adjuvant treatments. Recent research has shown that natural compounds, such as genistein, have chemotherapeutic and anticancer effects, but the mechanisms of action of genistein and its molecular targets in human colon cells have not been fully elucidated. The results reported in relation to non-malignant cell lines are also unclear, which does not allow evidence of the selectivity that this compound may have. Therefore, in this work, genistein was evaluated in vitro in both cancer cell lines SW480 and SW620 and in the non-malignant cell line HaCaT. The results obtained show that genistein has selectivity for the SW480 and SW620 cell lines. In addition, it inhibits cell viability and has an antiproliferative effect in a dose-dependent manner. Increased production of reactive oxygen species (ROS) was also found, suggesting an association with the cell death process through various mechanisms. Finally, the encapsulation strategy that was proposed made it possible to demonstrate that bacterial nanocellulose (BNC) is capable of protecting genistein from the acidic conditions of gastric fluid and also allows the release of the compound in the colonic fluid. This would allow genistein to act locally in the mucosa of the colon where the first stages of CRC occur.